Brochure | October 29, 2025

TheraPEAK® AmpliCell® Recombinant Cytokines

Source: Lonza
scientist in lab microscope-GettyImages-1867575565

AmpliCell® recombinant cytokines deliver reliable, consistent, and native-like performance for research, cell therapy, and biomanufacturing applications. These HEK293-expressed cytokines are engineered for high biological activity, ensuring proper folding and glycosylation to closely mimic the native human form, which reduces variability compared to E. coli-expressed alternatives.

Optimized for demanding workflows, such as ex vivo T cell expansion and NK cell activation, AmpliCell® provides a consistent, high-quality stimulus to offset the unpredictable nature of starting cells. Products offer high potency, lot-to-lot consistency, and low endotoxin safety profiles. Importantly, these cytokines are available in both Research Use Only (RUO) and GMP-grade formats, and the product remains the same, ensuring a smooth, streamlined transition from discovery to clinical development. Discover the data on high T cell expansion and viability.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online